IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma
Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This prospective, multicenter, single-arm, open-label phase II clinical study aimed to investigate the efficacy and safety of intensity-modulated radiotherapy combined with lobaplatin-based concurrent chemotherapy in the treatment of elderly patients with nasopharyngeal carcinoma
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of Xiamen University